Similar articles for PMID: 3262725

Year	Number of Results
1979	1
1985	2
1988	1
1990	3
1991	3
1992	6
1993	1
1994	2
1995	3
1996	3
1998	2
1999	1
2000	1
2002	5
2003	2
2006	2
2008	1
2014	1
2015	1
2021	0

1

In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography.

Martiat P, Ferrant A, Labar D, Cogneau M, Bol A, Michel C, Michaux JL, Sokal G. Martiat P, et al. J Nucl Med. 1988 Oct;29(10):1633-7. J Nucl Med. 1988. PMID: 3262725 Free article.

2

Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL.

Jerusalem GH, Beguin YP. Jerusalem GH, et al. Clin Lymphoma. 2002 Jun;3(1):56-61. doi: 10.3816/clm.2002.n.012. Clin Lymphoma. 2002. PMID: 12141957 Review.

3

Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.

Nuutinen J, Leskinen S, Lindholm P, Söderström KO, Någren K, Huhtala S, Minn H. Nuutinen J, et al. Eur J Nucl Med. 1998 Jul;25(7):729-35. doi: 10.1007/s002590050276. Eur J Nucl Med. 1998. PMID: 9662595 Clinical Trial.

4

Predicting malignancy grade with PET in non-Hodgkin's lymphoma.

Rodriguez M, Rehn S, Ahlström H, Sundström C, Glimelius B. Rodriguez M, et al. J Nucl Med. 1995 Oct;36(10):1790-6. J Nucl Med. 1995. PMID: 7562044 Free article.

5

Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.

Leskinen-Kallio S, Ruotsalainen U, Någren K, Teräs M, Joensuu H. Leskinen-Kallio S, et al. J Nucl Med. 1991 Jun;32(6):1211-8. J Nucl Med. 1991. PMID: 2045935 Free article.

6

[Correlation analysis between patlak plot and DAR using 11C-methionine PET].

Yoshida H, Yoshikawa K, Imazeki K, Yoshida K, Uchida Y, Hatano K, Uno K, Arimizu N. Yoshida H, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 1995 Jul;55(8):582-6. Nihon Igaku Hoshasen Gakkai Zasshi. 1995. PMID: 7638054 Japanese.

7

Brain tumor imaging with PET and 2-[carbon-11]thymidine.

Vander Borght T, Pauwels S, Lambotte L, Labar D, De Maeght S, Stroobandt G, Laterre C. Vander Borght T, et al. J Nucl Med. 1994 Jun;35(6):974-82. J Nucl Med. 1994. PMID: 8195884 Free article.

8

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.

Querellou S, Valette F, Bodet-Milin C, Oudoux A, Carlier T, Harousseau JL, Chatal JF, Couturier O. Querellou S, et al. Ann Hematol. 2006 Nov;85(11):759-67. doi: 10.1007/s00277-006-0151-z. Epub 2006 Jul 27. Ann Hematol. 2006. PMID: 16871391

9

Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine.

Vander Borght T, Lambotte L, Pauwels S, Labar D, Beckers C, Dive C. Vander Borght T, et al. Gastroenterology. 1991 Sep;101(3):794-9. doi: 10.1016/0016-5085(91)90541-r. Gastroenterology. 1991. PMID: 1860641

10

Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma?

Champion PE, Groshar D, Hooper HR, Palmer M, Catz Z, Belch A, McEwan A. Champion PE, et al. Nucl Med Commun. 1992 Oct;13(10):730-7. Nucl Med Commun. 1992. PMID: 1491837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed